Myristoyl Pentapeptide-17
Overview
Myristoyl Pentapeptide-17 is a lipopeptide composed of a pentapeptide sequence conjugated to myristic acid to facilitate penetration of the hair follicle and dermal layers. It is marketed primarily for enhancement of eyelash and eyebrow growth through proposed stimulation of keratin gene expression and prolongation of the anagen phase of the hair cycle. The peptide is intended for cosmetic applications related to hair conditioning and growth.
Key Research Findings
Preclinical keratinocyte culture studies have suggested increased keratin synthesis, and small consumer studies have reported subjective improvements in eyelash length and thickness. No randomized, placebo-controlled trials have been published in peer-reviewed ophthalmology or dermatology journals, and the peptide lacks regulatory approval for hair growth indications.
Topical
Research Phase
Interested in Myristoyl Pentapeptide-17?
Find a verified provider experienced with Myristoyl Pentapeptide-17 protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Myristoyl Pentapeptide-17 ProviderRelated Peptides
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.
Argireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.
Matrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.
Matrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.